Yatabemachi, Japan

Mannen Mishima


Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Yatabemachi, JP (1984 - 1986)
  • Ibaragi, JP (1987)

Company Filing History:


Years Active: 1984-1987

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mannen Mishima: Innovator in Non-Steroidal Anti-Inflammatory Drugs

Introduction

Mannen Mishima is a notable inventor based in Yatabemachi, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-steroidal anti-inflammatory drugs. With a total of 3 patents to his name, Mishima's work has the potential to impact the medical community positively.

Latest Patents

Mishima's latest patents focus on polyprenyl compounds and their applications in medicine. These patents disclose non-steroidal anti-inflammatory drugs that are polyprenyl alcohol esters of indolyl lower carboxylic acids, phenyl lower carboxylic acids, acetyl salicylic acid, anthranilic acid, and their derivatives. This innovative approach to drug formulation showcases his commitment to advancing medical science.

Career Highlights

Mannen Mishima is currently associated with Eisai Company, Limited, where he continues to work on groundbreaking pharmaceutical innovations. His expertise in the field has led to the development of effective treatments that address various health issues.

Collaborations

Mishima has collaborated with esteemed colleagues, including Isao Yamatsu and Shinya Abe. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Mannen Mishima's contributions to the field of pharmaceuticals, particularly in non-steroidal anti-inflammatory drugs, highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments, benefiting countless individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…